Valentin has pleaded not guilty and maintains his innocence, telling the court that he is eager to return to his job as an ...
LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...
GSK will receive $300 million upfront from Alfasigma for linerixibat, plus $100 million upon anticipated FDA approval and additional regulatory and sales-based milestones with tiered double-digit ...
Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Dyne Therapeutics, Inc. ( DYN) TD Cowen 46th Annual Health Care Conference March 4, ...
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...
Leerink Global Healthcare Conference 2026 March 9, 2026 10:40 AM EDTCompany ParticipantsMatt Sims - Vice President of ...
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 ...
At the center of the film are Bridgeport natives Roland Whitley, Louis L. Reed and Tiheba Bain.
Partnership leverages Tenacia's expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights ...
The weekend attack brought the death toll to at least 157 people since the administration began targeting the alleged drug ...
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...
"Lori and I mourn with the Pennsylvania State Police family and with all of our law enforcement partners. I’ve directed flags across our Commonwealth to be lowered Monday in hon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results